![Frank Condella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Condella
Direttore/Membro del Consiglio presso
Palladio Biosciences, Inc.
Patrimonio netto: 146 469 $ in data 31/08/2026
Profilo
Frank C.
Condella is currently an Independent Director at Palladio Biosciences, Inc. Formerly, Mr. Condella was President & Chief Executive Officer at Alpharma Specialty Pharma LLC from 2000 to 2001 and at FH Faulding & Co. Ltd. during the same period.
Served as Chief Executive Officer at Faulding Pharmaceuticals Plc.
Held the position of Chairman at Mayne Pharma Group Ltd. from 2021 to 2026.
Was Non-Executive Vice Chairman at Vectura Group Ltd. from 2016 to 2018.
Chaired The Polycystic Kidney Disease Research Foundation.
Served as Non-Executive Director at Catalent JNP, Inc. from 2016 to 2017.
Was President-Europe & Managing Director-UK at IVAX LLC from 2002 to 2006.
Held Non-Executive Director roles at SkyePharma Plc (2009-2010), Fulcrum Pharma Plc, Prosonix Ltd., and was an Independent Director at Fertin Pharma A. Served as Vice President-Specialty Care Products at Roche Holding AG and Hoffmann-La Roche, Inc. Education includes undergraduate and MBAistration degrees from Northeastern University and an MBAistration from D'Amore-Mckim School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2025 | 65.929 ( 0,08% ) | 146 469 $ | 31/08/2026 |
Posizioni attive di Frank Condella
| Società | Posizione | Inizio |
|---|---|---|
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Frank Condella
| Società | Posizione | Fine |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Presidente | 14/01/2026 |
| VECTURA GROUP | Direttore/Membro del Consiglio | 31/10/2018 |
| JUNIPER PHARMACEUTICALS INC | Amministratore Delegato | 01/08/2016 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Corporate Officer/Principal | - |
Alpharma Specialty Pharma LLC
 Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Distributes multi-source injectable pharmaceutical drugs | Presidente | 01/10/2001 |
Formazione di Frank Condella
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Alpharma Specialty Pharma LLC
Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Distributes multi-source injectable pharmaceutical drugs | Distribution Services |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Health Technology |
FH Faulding & Co. Ltd.
 FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fertin Pharma A/S
 Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Consumer Non-Durables |
Prosonix Ltd.
 Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Develops a portfolio of inhaled respiratory medicines | Health Technology |
The Polycystic Kidney Disease Research Foundation
 The Polycystic Kidney Disease Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit healthcare organization that focused on polycystic kidney diseases | Commercial Services |
D'Amore-Mckim School of Business
 D'Amore-Mckim School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Group Ltd.
 Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Faulding Pharmaceuticals Plc | |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
